FRI0577 Synovium Pathology and the Image of Ultrasonography of the Joints in the Patients with RA Treated by Biological Agent

BackgroundIn the treatment of rheumatoid arthritis (RA), early diagnosis and tight control increased their importance in the era of biological therapy. Ultrasonography (US) of the various joints enables an evaluation of synovits and bone erosion in real time. It is proved to be useful to detect syno...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of the rheumatic diseases 2015-06, Vol.74 (Suppl 2), p.636-637
Hauptverfasser: Abe, A., Ishikawa, H., Murasawa, A., Wakaki, K.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 637
container_issue Suppl 2
container_start_page 636
container_title Annals of the rheumatic diseases
container_volume 74
creator Abe, A.
Ishikawa, H.
Murasawa, A.
Wakaki, K.
description BackgroundIn the treatment of rheumatoid arthritis (RA), early diagnosis and tight control increased their importance in the era of biological therapy. Ultrasonography (US) of the various joints enables an evaluation of synovits and bone erosion in real time. It is proved to be useful to detect synovitis in the early stage of the disease. And it is useful for a comparison of the local disease activity at various stages.ObjectivesThe objectives of this study were to investigate whether the image of ultrasonography (US) at the operated joint reflect synovium pathology or clinical indicators, and to compare the results in the patient treated by non-biological agent (NonBio) and biological agent (Bio).MethodsRA related orthopaedic surgery was performed at 493 joints during the period betweeen January, 2011 and September, 2014. Preoperatively, US was performed and grade of Power Doppler (PD) signal was weighed. The evaluation including the Rooney score and Wakaki score of the synovium pathology organization that the synovium tissue collected at the time of the operation. DAS28-ESR(4), serum MMP-3, CRP were investigated. The sites of surgical operation were 8 shoulders, 64 knees, 47 elbows, 144 wrists, 17 ankles, 86 toes, 127 fingers. Number of the joints treated with Bio was 126 joints, and that with non-Bio was 367 joints. IFX was used in 20 patients, ETN in 42, TCZ in 30, ADA in 13, ABT in 9, GLM in 9, and CZP in 3.ResultsThe patients treated with Bio were significantly lower than those treated with non-Bio in PD signal of the operated joint (1.17±1.03, 1.59±0.98, p=7.06E-05), DAS28 (3.15±1.19, 3.82±1.08, p=1.12E-07), MMP-3 (116.2±120.0, 157.1±169.5, p=0.0034), Rooney score (24.13±8.49, 27.79±8.92, p=6.19E-08). The patients treated with TCZ were significantly lower than those treated with NonBio in PD signal (1.03±0.93, 1.59±0.98, p=0.0033), DAS28 (2.79±1.26, 3.82±1.08, p=0.0001). Rooney item score “fibrosis” in patients treated with IFX (9.30±1.49, p=0.001) and TCZ (9.03±1.97, p=0.001) were significantly higher than those in the patients treated with NonBio (7.89±1.90). “Synoviocyte hyperplasia” (1.17±1.12, 0.9±1.21), three items of lymphocytes: “perivascular infiltrates of lymphocytes” (1.35±2.70, 2.33±3.10),”focal aggregates of lymphocytes” (1.05±1.67, 1.67±2.28), “diffuse infiltrates of lymphocytes” (0.95±2.06, 1.37±2.09) in the patients treated with IFX or TCZ were lower than those treated with NonBio (1.99±1.39, p=0.0008, p=0.0005, 4.60±3.70, p=3.42E-05
doi_str_mv 10.1136/annrheumdis-2015-eular.1782
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1901803632</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4322504423</sourcerecordid><originalsourceid>FETCH-LOGICAL-b1272-85478172be4a80ebc5dfb3798dc3baab3839767e01e83b383dbfbb3a832b4dd3</originalsourceid><addsrcrecordid>eNqVkM1OwzAQhC0EEqXwDpZ6TrHjJHbFqVT8FFUClXK27MRJXCVxsRNQTnDhRXkS4pYDV06r2Z2ZlT4AJhhNMSbJpWgaW6quzrQLQoTjQHWVsFNMWXgERjhK2LBO0DEYIYRIEM0SegrOnNsOEjHMRuDjdr1EMaXfn1_PfWPedFfDJ9GWpjJFD0WTwbZUcFmLQkGTw5eqtcKZxhRW7Mrer_z9weimdVA3ezXktfL6XbclXM_hxirRqgzKHl5r36xTUcF5MZjOwUkuKqcufucYbG5vNov7YPV4t1zMV4HEIQ0DFkeUYRpKFQmGlEzjLJeEzliWEimEJIzMaEIVwooRrzKZS0kEI6GMsoyMweRQu7PmtVOu5VvT2Wb4yPEMYYZIQsLBdXVwpdY4Z1XOd1bXwvYcI-6B8z_AuQfO98C5Bz6kk0Na1tt_BX8A3bqOGQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1901803632</pqid></control><display><type>article</type><title>FRI0577 Synovium Pathology and the Image of Ultrasonography of the Joints in the Patients with RA Treated by Biological Agent</title><source>BMJ Journals - NESLi2</source><creator>Abe, A. ; Ishikawa, H. ; Murasawa, A. ; Wakaki, K.</creator><creatorcontrib>Abe, A. ; Ishikawa, H. ; Murasawa, A. ; Wakaki, K.</creatorcontrib><description>BackgroundIn the treatment of rheumatoid arthritis (RA), early diagnosis and tight control increased their importance in the era of biological therapy. Ultrasonography (US) of the various joints enables an evaluation of synovits and bone erosion in real time. It is proved to be useful to detect synovitis in the early stage of the disease. And it is useful for a comparison of the local disease activity at various stages.ObjectivesThe objectives of this study were to investigate whether the image of ultrasonography (US) at the operated joint reflect synovium pathology or clinical indicators, and to compare the results in the patient treated by non-biological agent (NonBio) and biological agent (Bio).MethodsRA related orthopaedic surgery was performed at 493 joints during the period betweeen January, 2011 and September, 2014. Preoperatively, US was performed and grade of Power Doppler (PD) signal was weighed. The evaluation including the Rooney score and Wakaki score of the synovium pathology organization that the synovium tissue collected at the time of the operation. DAS28-ESR(4), serum MMP-3, CRP were investigated. The sites of surgical operation were 8 shoulders, 64 knees, 47 elbows, 144 wrists, 17 ankles, 86 toes, 127 fingers. Number of the joints treated with Bio was 126 joints, and that with non-Bio was 367 joints. IFX was used in 20 patients, ETN in 42, TCZ in 30, ADA in 13, ABT in 9, GLM in 9, and CZP in 3.ResultsThe patients treated with Bio were significantly lower than those treated with non-Bio in PD signal of the operated joint (1.17±1.03, 1.59±0.98, p=7.06E-05), DAS28 (3.15±1.19, 3.82±1.08, p=1.12E-07), MMP-3 (116.2±120.0, 157.1±169.5, p=0.0034), Rooney score (24.13±8.49, 27.79±8.92, p=6.19E-08). The patients treated with TCZ were significantly lower than those treated with NonBio in PD signal (1.03±0.93, 1.59±0.98, p=0.0033), DAS28 (2.79±1.26, 3.82±1.08, p=0.0001). Rooney item score “fibrosis” in patients treated with IFX (9.30±1.49, p=0.001) and TCZ (9.03±1.97, p=0.001) were significantly higher than those in the patients treated with NonBio (7.89±1.90). “Synoviocyte hyperplasia” (1.17±1.12, 0.9±1.21), three items of lymphocytes: “perivascular infiltrates of lymphocytes” (1.35±2.70, 2.33±3.10),”focal aggregates of lymphocytes” (1.05±1.67, 1.67±2.28), “diffuse infiltrates of lymphocytes” (0.95±2.06, 1.37±2.09) in the patients treated with IFX or TCZ were lower than those treated with NonBio (1.99±1.39, p=0.0008, p=0.0005, 4.60±3.70, p=3.42E-05, p=0.0006, 3.74±3.25, p=4.29E-07, p=4.03E-05, 3.31±3.36, p=0.0001, p=3.60E-05).ConclusionsThe activity of RA synovitis at the operated site was suppressed in the patients treated with Bio. Disease activity of RA was suppressed in the patients treated with Bio. There were some differences in clinical data, pathological score, PDS and DAS among Bio.Disclosure of InterestNone declared</description><identifier>ISSN: 0003-4967</identifier><identifier>EISSN: 1468-2060</identifier><identifier>DOI: 10.1136/annrheumdis-2015-eular.1782</identifier><identifier>CODEN: ARDIAO</identifier><language>eng</language><publisher>Kidlington: Elsevier Limited</publisher><ispartof>Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.636-637</ispartof><rights>2015, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><rights>Copyright: 2015 (c) 2015, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttp://ard.bmj.com/content/74/Suppl_2/636.3.full.pdf$$EPDF$$P50$$Gbmj$$H</linktopdf><linktohtml>$$Uhttp://ard.bmj.com/content/74/Suppl_2/636.3.full$$EHTML$$P50$$Gbmj$$H</linktohtml><link.rule.ids>114,115,314,776,780,3183,23550,27901,27902,77342,77373</link.rule.ids></links><search><creatorcontrib>Abe, A.</creatorcontrib><creatorcontrib>Ishikawa, H.</creatorcontrib><creatorcontrib>Murasawa, A.</creatorcontrib><creatorcontrib>Wakaki, K.</creatorcontrib><title>FRI0577 Synovium Pathology and the Image of Ultrasonography of the Joints in the Patients with RA Treated by Biological Agent</title><title>Annals of the rheumatic diseases</title><description>BackgroundIn the treatment of rheumatoid arthritis (RA), early diagnosis and tight control increased their importance in the era of biological therapy. Ultrasonography (US) of the various joints enables an evaluation of synovits and bone erosion in real time. It is proved to be useful to detect synovitis in the early stage of the disease. And it is useful for a comparison of the local disease activity at various stages.ObjectivesThe objectives of this study were to investigate whether the image of ultrasonography (US) at the operated joint reflect synovium pathology or clinical indicators, and to compare the results in the patient treated by non-biological agent (NonBio) and biological agent (Bio).MethodsRA related orthopaedic surgery was performed at 493 joints during the period betweeen January, 2011 and September, 2014. Preoperatively, US was performed and grade of Power Doppler (PD) signal was weighed. The evaluation including the Rooney score and Wakaki score of the synovium pathology organization that the synovium tissue collected at the time of the operation. DAS28-ESR(4), serum MMP-3, CRP were investigated. The sites of surgical operation were 8 shoulders, 64 knees, 47 elbows, 144 wrists, 17 ankles, 86 toes, 127 fingers. Number of the joints treated with Bio was 126 joints, and that with non-Bio was 367 joints. IFX was used in 20 patients, ETN in 42, TCZ in 30, ADA in 13, ABT in 9, GLM in 9, and CZP in 3.ResultsThe patients treated with Bio were significantly lower than those treated with non-Bio in PD signal of the operated joint (1.17±1.03, 1.59±0.98, p=7.06E-05), DAS28 (3.15±1.19, 3.82±1.08, p=1.12E-07), MMP-3 (116.2±120.0, 157.1±169.5, p=0.0034), Rooney score (24.13±8.49, 27.79±8.92, p=6.19E-08). The patients treated with TCZ were significantly lower than those treated with NonBio in PD signal (1.03±0.93, 1.59±0.98, p=0.0033), DAS28 (2.79±1.26, 3.82±1.08, p=0.0001). Rooney item score “fibrosis” in patients treated with IFX (9.30±1.49, p=0.001) and TCZ (9.03±1.97, p=0.001) were significantly higher than those in the patients treated with NonBio (7.89±1.90). “Synoviocyte hyperplasia” (1.17±1.12, 0.9±1.21), three items of lymphocytes: “perivascular infiltrates of lymphocytes” (1.35±2.70, 2.33±3.10),”focal aggregates of lymphocytes” (1.05±1.67, 1.67±2.28), “diffuse infiltrates of lymphocytes” (0.95±2.06, 1.37±2.09) in the patients treated with IFX or TCZ were lower than those treated with NonBio (1.99±1.39, p=0.0008, p=0.0005, 4.60±3.70, p=3.42E-05, p=0.0006, 3.74±3.25, p=4.29E-07, p=4.03E-05, 3.31±3.36, p=0.0001, p=3.60E-05).ConclusionsThe activity of RA synovitis at the operated site was suppressed in the patients treated with Bio. Disease activity of RA was suppressed in the patients treated with Bio. There were some differences in clinical data, pathological score, PDS and DAS among Bio.Disclosure of InterestNone declared</description><issn>0003-4967</issn><issn>1468-2060</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNqVkM1OwzAQhC0EEqXwDpZ6TrHjJHbFqVT8FFUClXK27MRJXCVxsRNQTnDhRXkS4pYDV06r2Z2ZlT4AJhhNMSbJpWgaW6quzrQLQoTjQHWVsFNMWXgERjhK2LBO0DEYIYRIEM0SegrOnNsOEjHMRuDjdr1EMaXfn1_PfWPedFfDJ9GWpjJFD0WTwbZUcFmLQkGTw5eqtcKZxhRW7Mrer_z9weimdVA3ezXktfL6XbclXM_hxirRqgzKHl5r36xTUcF5MZjOwUkuKqcufucYbG5vNov7YPV4t1zMV4HEIQ0DFkeUYRpKFQmGlEzjLJeEzliWEimEJIzMaEIVwooRrzKZS0kEI6GMsoyMweRQu7PmtVOu5VvT2Wb4yPEMYYZIQsLBdXVwpdY4Z1XOd1bXwvYcI-6B8z_AuQfO98C5Bz6kk0Na1tt_BX8A3bqOGQ</recordid><startdate>201506</startdate><enddate>201506</enddate><creator>Abe, A.</creator><creator>Ishikawa, H.</creator><creator>Murasawa, A.</creator><creator>Wakaki, K.</creator><general>Elsevier Limited</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope></search><sort><creationdate>201506</creationdate><title>FRI0577 Synovium Pathology and the Image of Ultrasonography of the Joints in the Patients with RA Treated by Biological Agent</title><author>Abe, A. ; Ishikawa, H. ; Murasawa, A. ; Wakaki, K.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b1272-85478172be4a80ebc5dfb3798dc3baab3839767e01e83b383dbfbb3a832b4dd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Abe, A.</creatorcontrib><creatorcontrib>Ishikawa, H.</creatorcontrib><creatorcontrib>Murasawa, A.</creatorcontrib><creatorcontrib>Wakaki, K.</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><jtitle>Annals of the rheumatic diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Abe, A.</au><au>Ishikawa, H.</au><au>Murasawa, A.</au><au>Wakaki, K.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>FRI0577 Synovium Pathology and the Image of Ultrasonography of the Joints in the Patients with RA Treated by Biological Agent</atitle><jtitle>Annals of the rheumatic diseases</jtitle><date>2015-06</date><risdate>2015</risdate><volume>74</volume><issue>Suppl 2</issue><spage>636</spage><epage>637</epage><pages>636-637</pages><issn>0003-4967</issn><eissn>1468-2060</eissn><coden>ARDIAO</coden><abstract>BackgroundIn the treatment of rheumatoid arthritis (RA), early diagnosis and tight control increased their importance in the era of biological therapy. Ultrasonography (US) of the various joints enables an evaluation of synovits and bone erosion in real time. It is proved to be useful to detect synovitis in the early stage of the disease. And it is useful for a comparison of the local disease activity at various stages.ObjectivesThe objectives of this study were to investigate whether the image of ultrasonography (US) at the operated joint reflect synovium pathology or clinical indicators, and to compare the results in the patient treated by non-biological agent (NonBio) and biological agent (Bio).MethodsRA related orthopaedic surgery was performed at 493 joints during the period betweeen January, 2011 and September, 2014. Preoperatively, US was performed and grade of Power Doppler (PD) signal was weighed. The evaluation including the Rooney score and Wakaki score of the synovium pathology organization that the synovium tissue collected at the time of the operation. DAS28-ESR(4), serum MMP-3, CRP were investigated. The sites of surgical operation were 8 shoulders, 64 knees, 47 elbows, 144 wrists, 17 ankles, 86 toes, 127 fingers. Number of the joints treated with Bio was 126 joints, and that with non-Bio was 367 joints. IFX was used in 20 patients, ETN in 42, TCZ in 30, ADA in 13, ABT in 9, GLM in 9, and CZP in 3.ResultsThe patients treated with Bio were significantly lower than those treated with non-Bio in PD signal of the operated joint (1.17±1.03, 1.59±0.98, p=7.06E-05), DAS28 (3.15±1.19, 3.82±1.08, p=1.12E-07), MMP-3 (116.2±120.0, 157.1±169.5, p=0.0034), Rooney score (24.13±8.49, 27.79±8.92, p=6.19E-08). The patients treated with TCZ were significantly lower than those treated with NonBio in PD signal (1.03±0.93, 1.59±0.98, p=0.0033), DAS28 (2.79±1.26, 3.82±1.08, p=0.0001). Rooney item score “fibrosis” in patients treated with IFX (9.30±1.49, p=0.001) and TCZ (9.03±1.97, p=0.001) were significantly higher than those in the patients treated with NonBio (7.89±1.90). “Synoviocyte hyperplasia” (1.17±1.12, 0.9±1.21), three items of lymphocytes: “perivascular infiltrates of lymphocytes” (1.35±2.70, 2.33±3.10),”focal aggregates of lymphocytes” (1.05±1.67, 1.67±2.28), “diffuse infiltrates of lymphocytes” (0.95±2.06, 1.37±2.09) in the patients treated with IFX or TCZ were lower than those treated with NonBio (1.99±1.39, p=0.0008, p=0.0005, 4.60±3.70, p=3.42E-05, p=0.0006, 3.74±3.25, p=4.29E-07, p=4.03E-05, 3.31±3.36, p=0.0001, p=3.60E-05).ConclusionsThe activity of RA synovitis at the operated site was suppressed in the patients treated with Bio. Disease activity of RA was suppressed in the patients treated with Bio. There were some differences in clinical data, pathological score, PDS and DAS among Bio.Disclosure of InterestNone declared</abstract><cop>Kidlington</cop><pub>Elsevier Limited</pub><doi>10.1136/annrheumdis-2015-eular.1782</doi><tpages>2</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0003-4967
ispartof Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.636-637
issn 0003-4967
1468-2060
language eng
recordid cdi_proquest_journals_1901803632
source BMJ Journals - NESLi2
title FRI0577 Synovium Pathology and the Image of Ultrasonography of the Joints in the Patients with RA Treated by Biological Agent
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-12T15%3A46%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=FRI0577%E2%80%85Synovium%20Pathology%20and%20the%20Image%20of%20Ultrasonography%20of%20the%20Joints%20in%20the%20Patients%20with%20RA%20Treated%20by%20Biological%20Agent&rft.jtitle=Annals%20of%20the%20rheumatic%20diseases&rft.au=Abe,%20A.&rft.date=2015-06&rft.volume=74&rft.issue=Suppl%202&rft.spage=636&rft.epage=637&rft.pages=636-637&rft.issn=0003-4967&rft.eissn=1468-2060&rft.coden=ARDIAO&rft_id=info:doi/10.1136/annrheumdis-2015-eular.1782&rft_dat=%3Cproquest_cross%3E4322504423%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1901803632&rft_id=info:pmid/&rfr_iscdi=true